CALGARY, ALBERTA -- (MARKET WIRE) -- May 03, 2007 -- Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE: SSS) has retained the services of MaisonBrison to assist in the Corporation's media and investor relations and corporate communications initiatives. Their mandate includes the execution of targeted communications strategies as well as a dedicated investor relations program to further position SCT within the financial markets.
